Health Highlights, April 7, 2022

• Tweet
• Pin It

Is the CDC in crisis? Former agency heads debate its future. A handful of former directors say they support a sweeping review of the agency that’s been ordered up by current director Dr. Rochelle Walensky. Read more

Experimental pill may fight antibiotic-resistant UTIs. The new pill, called tebipenem HBr, worked as well as a standard IV antibiotic in treating patients hospitalized with “complicated” UTIs, a study has found. Read more

Upped risk for clots lasts at least 6 months after COVID. A new study suggests that COVID-19 is an independent risk factor for deep vein thrombosis, pulmonary embolism and bleeding, researchers say. Read more

U.S. nursing home industry needs an overhaul. A major new report finds facilities awash in ineffective care and staffing shortages. Its authors call for sweeping changes in an industry whose failures have only been exacerbated by the pandemic. Read more

Are retooled COVID booster shots coming this fall? Federal health officials told an expert advisory panel on Wednesday that clinical trials of potential candidates would have to begin by next month, and a final formula chosen by June. Read more

Copyright © 2025 HealthDay. All rights reserved.

• Tweet
• Pin It